GlassScriptPhysician profile
Scott Maurer
NPI 1861554974
$1,363.63
in general payments reported to CMS, 2019-2025
22 companies · $621 in 2025
The $621 reported for 2025 was more than what 82% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $81.57 · 2022: $20.82 · 2023: $16.05 · 2024: $78.81 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $369.80 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $238.99 | 2019-2025 | Farxiga |
| Pfizer INC. | $97.38 | 2019-2025 | |
| Lilly USA, LLC | $95.33 | 2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $59.53 | 2019-2025 | Evenity |
| Merck Sharp & Dohme LLC | $52.23 | 2019-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Kowa Pharmaceuticals America, INC. | $51.49 | 2019-2024 | Zoryve |
| Exact Sciences Corporation | $44.67 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $36.81 | 2019 | |
| Amarin Pharma, INC. | $36.05 | 2019-2020 | |
| Astellas Pharma US INC | $34.17 | 2019 | |
| Bausch Health US, LLC | $32.79 | 2019 | |
| Adlon Therapeutics L.P. | $29.20 | 2019 | |
| Sumitomo Pharma America, INC. | $25.44 | 2025 | Gemtesa |
| Alkermes, INC. | $24.12 | 2025 | Vivitrol |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.78 | 2025 | |
| Glaxosmithkline, LLC. | $21.51 | 2025 | Trelegy Ellipta |
| Abbott Laboratories | $20.05 | 2025 | Freestyle Libre 3 |
| Seqirus USA INC | $19.92 | 2025 | Fluad, Flucelvax |
| E.R. Squibb & Sons, L.L.C. | $18.79 | 2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $17.41 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.17 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Maurer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.